Douglas Laboratories Canada
Flavonall
LNHPD
5431374
Formula hash
a489fc09106c
Catalog
321
products
With avoid flag
0
products
FDA recalls
0
history
CAERS
0
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category D
- GinkgoCategory D
LiverTox Category D (hepatotoxicity — separate concern from IARC Group 2B carcinogenicity classification). A handful of hepatitis reports.
LiverTox →
Supplement Facts
7 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Ginkgo biloba GinkgoherbUNII · 19FUJ2C58T LiverTox D | 40.0 mg | — |
| Ginkgo biloba GinkgoherbUNII · 19FUJ2C58T LiverTox D | — | — |
| Grape seed extract GrapeherbUNII · C34U15ICXA | 32.5 mg | — |
| Silybum marianum Milk Thistleherb LiverTox C | 87.5 mg | — |
| Camellia sinensis herb | 450.0 mg | — |
| Vitis vinifera Grapeherb | 50.0 mg | — |
| Vaccinium myrtillus other | 60.0 mg | — |